BMS 345541 (trifluoroacetate salt) (5 mg) IKK Inhibitor III; N1- (1, 8- dimethylimidazo[1, 2- a] quinoxalin- 4- yl) -1, 2- ethanediamine, trifluoroacetate salt Cayman 16667-5 2094.4/5 mg 详情
2-Amino-5-fluorobenzoic Acid (1 g) 5-FAA|5-Fluoroanthranilic Acid|NSC 513308; 2-amino-5-fluoro-benzoic acid Cayman 16669-1 677.6/1 g 详情
2-Amino-5-fluorobenzoic Acid (10 g) 5-FAA|5-Fluoroanthranilic Acid|NSC 513308; 2-amino-5-fluoro-benzoic acid Cayman 16669-10 5420.8/10 g 详情
2-Amino-5-fluorobenzoic Acid (5 g) 5-FAA|5-Fluoroanthranilic Acid|NSC 513308; 2-amino-5-fluoro-benzoic acid Cayman 16669-5 2879.8/5 g 详情
Flupirtine (maleate ) (100 mg) N-[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-carbamic acid, ethyl ester, 2Z-butenedioate Cayman 16674-100 1601.6/100 mg 详情
Flupirtine (maleate ) (25 mg) N-[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-carbamic acid, ethyl ester, 2Z-butenedioate Cayman 16674-25 446.6/25 mg 详情
Flupirtine (maleate ) (50 mg) N-[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-carbamic acid, ethyl ester, 2Z-butenedioate Cayman 16674-50 847/50 mg 详情
AZD 1080 (1 mg) 2- hydroxy- 3- [5- (4- morpholinylmethyl) - 2- pyridinyl]- 1H- indole- 5- carbonitrile Cayman 16676-1 754.6/1 mg 详情
AZD 1080 (10 mg) 2- hydroxy- 3- [5- (4- morpholinylmethyl) - 2- pyridinyl]- 1H- indole- 5- carbonitrile Cayman 16676-10 6036.8/10 mg 详情
AZD 1080 (25 mg) 2- hydroxy- 3- [5- (4- morpholinylmethyl) - 2- pyridinyl]- 1H- indole- 5- carbonitrile Cayman 16676-25 13213.2/25 mg 详情
AZD 1080 (5 mg) 2- hydroxy- 3- [5- (4- morpholinylmethyl) - 2- pyridinyl]- 1H- indole- 5- carbonitrile Cayman 16676-5 3403.4/5 mg 详情
Astragaloside A (1 mg) Astragaloside IV|Astramembrannin I; 20,24R-epoxy-16β,25-dihydroxy-3β-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6α-yl-β-D-glucopyranoside Cayman 16677-1 693/1 mg 详情
Astragaloside A (10 mg) Astragaloside IV|Astramembrannin I; 20,24R-epoxy-16β,25-dihydroxy-3β-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6α-yl-β-D-glucopyranoside Cayman 16677-10 5205.2/10 mg 详情
Astragaloside A (5 mg) Astragaloside IV|Astramembrannin I; 20,24R-epoxy-16β,25-dihydroxy-3β-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6α-yl-β-D-glucopyranoside Cayman 16677-5 2941.4/5 mg 详情
Astragaloside A (50 mg) Astragaloside IV|Astramembrannin I; 20,24R-epoxy-16β,25-dihydroxy-3β-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6α-yl-β-D-glucopyranoside Cayman 16677-50 13860/50 mg 详情
K02288 (1 mg) 3-[6-amino-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]-phenol Cayman 16678-1 446.6/1 mg 详情
K02288 (10 mg) 3-[6-amino-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]-phenol Cayman 16678-10 2910.6/10 mg 详情
Thrombin (human) (100 U) Activated Factor II [IIa] Cayman 13188-100U 规格或产品已更新 详情
K02288 (5 mg) 3-[6-amino-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]-phenol Cayman 16678-5 1678.6/5 mg 详情
K02288 (50 mg) 3-[6-amino-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]-phenol Cayman 16678-50 10056.2/50 mg 详情
P7C3 (10 mg) 3,6-dibromo-α-[(phenylamino)methyl]-9H-carbazole-9-ethanol Cayman 16682-10 2202.2/10 mg 详情
P7C3 (25 mg) 3,6-dibromo-α-[(phenylamino)methyl]-9H-carbazole-9-ethanol Cayman 16682-25 5174.4/25 mg 详情
P7C3 (5 mg) 3,6-dibromo-α-[(phenylamino)methyl]-9H-carbazole-9-ethanol Cayman 16682-5 1293.6/5 mg 详情
P7C3 (50 mg) 3,6-dibromo-α-[(phenylamino)methyl]-9H-carbazole-9-ethanol Cayman 16682-50 8408.4/50 mg 详情
LY2784544 (1 mg) 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-imidazo[1,2-b]pyridazin-6-amine Cayman 16705-1 1062.6/1 mg 详情
LY2784544 (10 mg) 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-imidazo[1,2-b]pyridazin-6-amine Cayman 16705-10 3927/10 mg 详情
LY2784544 (25 mg) 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-imidazo[1,2-b]pyridazin-6-amine Cayman 16705-25 7438.2/25 mg 详情
LY2784544 (5 mg) 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-imidazo[1,2-b]pyridazin-6-amine Cayman 16705-5 2387/5 mg 详情
MK 0752 (1 mg) cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)-cyclohexanepropanoic acid Cayman 16706-1 847/1 mg 详情
MK 0752 (10 mg) cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)-cyclohexanepropanoic acid Cayman 16706-10 5513.2/10 mg 详情
MK 0752 (5 mg) cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)-cyclohexanepropanoic acid Cayman 16706-5 3819.2/5 mg 详情
Baricitinib (1 mg) INCB 028050|LY3009104; 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile Cayman 16707-1 600.6/1 mg 详情
Baricitinib (10 mg) INCB 028050|LY3009104; 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile Cayman 16707-10 4512.2/10 mg 详情
Baricitinib (25 mg) INCB 028050|LY3009104; 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile Cayman 16707-25 9009/25 mg 详情
Baricitinib (5 mg) INCB 028050|LY3009104; 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile Cayman 16707-5 2710.4/5 mg 详情
SR 3677 (1 mg) N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxin-2-carboxamide Cayman 16708-1 539/1 mg 详情
SR 3677 (10 mg) N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxin-2-carboxamide Cayman 16708-10 2695/10 mg 详情
SR 3677 (25 mg) N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxin-2-carboxamide Cayman 16708-25 6067.6/25 mg 详情
SR 3677 (5 mg) N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxin-2-carboxamide Cayman 16708-5 1478.4/5 mg 详情
Pacritinib (1 mg) SB 1518; 11-[2-(1-pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16E,21,23-decaene Cayman 16709-1 1031.8/1 mg 详情
Pacritinib (5 mg) SB 1518; 11-[2-(1-pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16E,21,23-decaene Cayman 16709-5 4312/5 mg 详情
Pacritinib (500 礸) SB 1518; 11-[2-(1-pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16E,21,23-decaene Cayman 16709-500 539/500 ug 详情
Avagacestat (1 mg) BMS 708163; (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-pentanamide Cayman 16711-1 539/1 mg 详情
Avagacestat (10 mg) BMS 708163; (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-pentanamide Cayman 16711-10 4312/10 mg 详情
Avagacestat (5 mg) BMS 708163; (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-pentanamide Cayman 16711-5 2433.2/5 mg 详情
LY2811376 (1 mg) (4S)-4-[2,4-difluoro-5-(5-pyrimidinyl)phenyl]-5,6-dihydro-4-methyl-4H-1,3-thiazin-2-amine Cayman 16712-1 539/1 mg 详情
LY2811376 (10 mg) (4S)-4-[2,4-difluoro-5-(5-pyrimidinyl)phenyl]-5,6-dihydro-4-methyl-4H-1,3-thiazin-2-amine Cayman 16712-10 4312/10 mg 详情
LY2811376 (5 mg) (4S)-4-[2,4-difluoro-5-(5-pyrimidinyl)phenyl]-5,6-dihydro-4-methyl-4H-1,3-thiazin-2-amine Cayman 16712-5 2433.2/5 mg 详情
LY2811376 (50 mg) (4S)-4-[2,4-difluoro-5-(5-pyrimidinyl)phenyl]-5,6-dihydro-4-methyl-4H-1,3-thiazin-2-amine Cayman 16712-50 13475/50 mg 详情
Semagacestat (1 mg) LY450139; (2S)-2-hydroxy-3-methyl-N-[(1S)-1-methyl-2-oxo-2-[[(1S)-2,3,4,5-tetrahydro-3-methyl-2-oxo-1H-3-benzazepin-1-yl]amino]ethyl]-butanamide Cayman 16713-1 539/1 mg 详情
首页 公司简介 新闻中心 产品中心 特色产品 技术专栏 在线订购 联系我们

版权所有 艾美捷科技有限公司

地址:武汉市洪山区光谷大道35号光谷总部国际二期时代1栋13楼 邮政编码:430074

电话:+86-027-59626688 全国免费技术支持: 400-6800-868 传真:+86-027-59716800

鄂ICP备10204150号

Abbkine Scientific   亚科因科技